Strikingly, isolated CSP-positive NSCLC cells showed elevated expression of plectin and key stem cell markers (ALDH1A3, SOX2, and CD44) and increased clonogenicity compared to CSP-negative cells from the same cell line [16]. The gene discussed is PLEC; the disease is non-small cell lung carcinoma.